SCHEMBL6073343

SCHEMBL6073343

CN(C)C(=O)C(Br)(c1ccccc1)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 5/20 0.53
DRD3 P35462 4/20 0.53
DRD4 P21917 3/20 0.53
DRD2 P14416 2/20 0.44
KCNN4 O15554 2/20 0.43
KMT2A Q03164 2/20 0.42
MAPT P10636 1/20 0.42
CYP2C19 P33261 2/20 0.41
MEN1 O00255 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HIF1A Q16665 1/20 0.41
CYP1A2 P05177 2/20 0.40
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5642972 0.78 KMT2A (0.57) OPRM1DRD3DRD4DRD2KCNN4
SCHEMBL10814384 0.78 OPRM1 (0.53) OPRM1DRD3DRD4DRD2KCNN4
SCHEMBL375036 0.78 OPRM1 (0.53) OPRM1DRD3DRD4DRD2KCNN4
SCHEMBL16158180 0.77 OPRM1 (0.51) OPRM1DRD3DRD4DRD2KCNN4
SCHEMBL6073374 0.77 CYP1A2 (0.59) OPRM1DRD3DRD4DRD2KCNN4
SCHEMBL11536202 0.76 KMT2A (0.48) OPRM1DRD3DRD4KCNN4KMT2A
SCHEMBL10814377 0.75 OPRM1 (0.50) OPRM1DRD3DRD4DRD2KCNN4
SCHEMBL31308059 0.75 OPRM1 (0.46) OPRM1DRD3DRD4DRD2KCNN4
SCHEMBL11884455 0.75 MAPT (0.46) KCNN4KMT2AMAPTCYP2C19CYP3A4
SCHEMBL1414646 0.74 CYP1A2 (0.48) KCNN4KMT2AMAPTCYP2C19HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006136823-A1 HETEROCYCLIC CONTAINING AMINES AS KINASE B INHIBITORS ASTEX THERAPEUTICS LIMITED (GB) 2006-12-28 WO disclosed